Both Fasting and Glucose-Stimulated Proinsulin Levels Predict Hyperglycemia and Incident Type 2 Diabetes: A Population-Based Study of 9,396 Finnish Men
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hyperproinsulinemia is an indicator of β-cell dysfunction, and fasting proinsulin levels are elevated in patients with hyperglycemia. It is not known whether proinsulin levels after a glucose load are better predictors of hyperglycemia and type 2 diabetes than fasting proinsulin. METHODS: Participants were 9,396 Finnish men (mean±SD, age 57.3±7.1 years, BMI 27.0±4.0 kg/m2) of the population-based METabolic Syndrome In Men Study who were non-diabetic at the recruitment, and who participated in a 6-year follow-up study. Proinsulin and insulin levels were measured in the fasting state and 30 and 120 min after an oral glucose load. Area under the curve (AUC) and proinsulin to insulin ratios were calculated. RESULTS: Fasting proinsulin, proinsulin at 30 min and proinsulin AUC during the first 30 min of an oral glucose tolerance test significantly predicted both the worsening of hyperglycemia and type 2 diabetes after adjustment for confounding factors. Further adjustment for insulin sensitivity (Matsuda index) or insulin secretion (Disposition index) weakened these associations. Insulin sensitivity had a major impact on these associations. CONCLUSION: Our results suggest that proinsulin in the fasting state and after an oral glucose load similarly predict the worsening of hyperglycemia and conversion to type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In healthy subjects, proinsulin accounts for up to 20% of the insulin levels in circulation, but in T2D this value can reach up to 50% and total proinsulin levels have shown to be higher in T2D patients than healthy controls, which suggests that dysfunctional processing and secretion of insulin by the remaining islet beta-cell population further contributes to the decreased insulin levels observed”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“Evaluation of insulin secretion (InsAUC0-30/GlucAUC0-30) and insulin sensitivity (Matsuda ISI) have been previously described [18,21].”
MethodStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s5 · Cited by 1,666
Leahy, J. L., Bonner-Weir, S., & Weir, G. C. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.442 · Cited by 357
Stančáková, A., Javorský, M., Kuulasmaa, T., Haffner, S. M., Kuusisto, J., & Laakso, M. (2009) · Diabetes · doi:10.2337/db08-1607 · Cited by 348 · cited 3×
“Evaluation of insulin secretion (InsAUC0-30/GlucAUC0-30) and insulin sensitivity (Matsuda ISI) have been previously described [18,21].”
MethodSelf-citationGlucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells
Schuit, F. C., In't Veld, P. A., & Pipeleers, D. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.3865 · Cited by 308 · cited 1×
“Prolonged exposure of β-cells to glucose results in abnormal proinsulin processing [7], which is related to the severity of hyperglycemia [3].”
BackgroundHuyghe, J. R., Jackson, A. U., Fogarty, M. P., Buchkovich, M. L., Stančáková, A., Stringham, H. M., Sim, X., Yang, L., Fuchsberger, C., Cederberg, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2507 · Cited by 282 · cited 1×
“Recent studies have shown that common and low-frequency gene variants regulate proinsulin levels [9], and that disruption of insulin receptor expression in beta-cells leads to poor proinsulin processing by altering the expression of carboxypeptidase E enzyme [10].”
BackgroundSelf-citationWard, W. K., LaCava, E. C., Paquette, T. L., Beard, J. C., Wallum, B. J., & Porte, D. (1987) · Diabetologia · doi:10.1007/bf00296991 · Cited by 275
Kahn, S. E., & Halban, P. A. (1997) · Diabetes · doi:10.2337/diab.46.11.1725 · Cited by 221
Kahn, S. E., & Halban, P. A. (1997) · Diabetes · doi:10.2337/diabetes.46.11.1725 · Cited by 221
Røder, M. E., Porte, D., Schwartz, R. S., & Kahn, S. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4544 · Cited by 207 · cited 1×
“Conflicting results between the studies could be explained by small sample sizes in previous studies, different methods to measure proinsulin, cross-reactivity of proinsulin with proinsulin split products, and hepatic clearance of insulin [11,33,34].”
ResultFasting proinsulin concentrations predict the development of type 2 diabetes.
Wareham, N. J., Byrne, C. D., Williams, R., Day, N. E., & Hales, C. N. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.262 · Cited by 173
Disproportionately Elevated Proinsulin in Pima Indians with Noninsulin-Dependent Diabetes Mellitus*
SAAD, M. F., KAHN, S. E., NELSON, R. G., PETTITT, D. J., KNOWLER, W. C., SCHWARTZ, M. W., KOWALYK, S., BENNETT, P. H., & PORTE, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1247 · Cited by 167 · cited 1×
“Prolonged exposure of β-cells to glucose results in abnormal proinsulin processing [7], which is related to the severity of hyperglycemia [3].”
BackgroundRoder, M. E. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.604 · Cited by 165
β-Cell Function Across the Spectrum of Glucose Tolerance in Obese Youth
Weiss, R., Caprio, S., Trombetta, M., Taksali, S. E., Tamborlane, W. V., & Bonadonna, R. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1735 · Cited by 164
Rhodes, C. J., & Alarcón, C. (1994) · Diabetes · doi:10.2337/diab.43.4.511 · Cited by 156
Fasting Intact Proinsulin Is a Highly Specific Predictor of Insulin Resistance in Type 2 Diabetes
Pfützner, A., Kunt, T., Hohberg, C., Mondok, A., Pahler, S., Konrad, T., Lübben, G., & Forst, T. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.682 · Cited by 149 · cited 2×
“Fasting proinsulin levels have been associated with insulin resistance [12] and type 2 diabetes [13–16], but not with family history of diabetes [17].”
BackgroundResultβ-Cell Dysfunction in Subjects With Impaired Glucose Tolerance and Early Type 2 Diabetes
Festa, A., Williams, K., Hanley, A. J. G., & Haffner, S. M. (2008) · Diabetes · doi:10.2337/db07-0954 · Cited by 128
Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects
Mykk�nen, L., Haffner, S. M., Kuusisto, J., Py�r�l�, K., Hales, C. N., & Laakso, M. (1995) · Diabetologia · doi:10.1007/bf00422366 · Cited by 96
Self-citationMykkänen, L., Haffner, S. M., Hales, C. N., Rönnemaa, T., & Laakso, M. (1997) · Diabetes · doi:10.2337/diab.46.12.1990 · Cited by 92
Self-citationMykkanen, L., Haffner, S. M., Hales, C. N., Ronnemaa, T., & Laakso, M. (1997) · Diabetes · doi:10.2337/diabetes.46.12.1990 · Cited by 92
Self-citationAlarcón, C., Leahy, J. L., Schuppin, G. T., & Rhodes, C. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117748 · Cited by 91 · cited 2×
“Mechanisms that could lead to elevated proinsulin levels indicating β-cell distress are a greater demand for insulin secretion due to hyperglycemia that depletes the mature insulin granules, the defective enzymatic proinsulin processing machinery, or the loss of β-cell viability or a combination of these mechanisms [4…”
BackgroundHanley, A. J. G., D’Agostino, R., Wagenknecht, L. E., Saad, M. F., Savage, P. J., Bergman, R., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1263 · Cited by 83
Proinsulin and Specific Insulin Concentration in High- and Low-Risk Populations for NIDDM
Haffner, S. M., Bowsher, R. R., Mykkänen, L., Hazuda, H. P., Mitchell, B. D., Valdez, R. A., Gingerich, R., Monterossa, A., & Stern, M. P. (1994) · Diabetes · doi:10.2337/diab.43.12.1490 · Cited by 83
Loopstra, R., Haffner, S. M., Lorenzo, C., Wagenknecht, L. E., & Hanley, A. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2322-2 · Cited by 74
Pradhan, A. D., Manson, J. E., Meigs, J. B., Rifai, N., Buring, J. E., Liu, S., & Ridker, P. M. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00061-5 · Cited by 73
Zethelius, B., Byberg, L., Hales, C. N., Lithell, H., & Berne, C. (2003) · Diabetologia · doi:10.1007/s00125-002-0995-2 · Cited by 71
Zethelius, B., Hales, C. N., Lithell, H. O., & Berne, C. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1433 · Cited by 60
Liew, C. W., Aßmann, A., Templin, A. T., Raum, J. C., Lipson, K. L., Rajan, S., Qiang, G., Hu, J., Kawamori, D., Lindberg, I., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323066111 · Cited by 50 · cited 1×
“Recent studies have shown that common and low-frequency gene variants regulate proinsulin levels [9], and that disruption of insulin receptor expression in beta-cells leads to poor proinsulin processing by altering the expression of carboxypeptidase E enzyme [10].”
BackgroundRelative Hyperproinsulinemia as a Sign of Islet Dysfunction in Women with Impaired Glucose Tolerance
Larsson, H., & Åhrén, B. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5717 · Cited by 50
Hyperproinsulinemia of Type II Diabetes Is Not Present Before the Development of Hyperglycemia
Birkeland, K. I., Torjesen, P. A., Eriksson, J. G., Vaaler, S., & Groop, L. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1307 · Cited by 46 · cited 1×
“Elevated level of glucose is the main stimulus for increased proinsulin synthesis and secretion [6].”
BackgroundKahn, S. E., Leonetti, D. L., Prigeon, R. L., Boyko, E. J., Bergstöm, R., & Fujimoto, W. Y. (1996) · Diabetic Medicine · doi:10.1002/dme.1996.13.s6.63 · Cited by 35
Grill, V., Dinesen, B., Carlsson, S., Efendic, S., Pedersen, O., & Ostenson, C.-G. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.9.834 · Cited by 23 · cited 2×
“Fasting proinsulin levels have been associated with insulin resistance [12] and type 2 diabetes [13–16], but not with family history of diabetes [17].”
BackgroundResultStümvoll, M., Fritsche, A., Stefan, N., Hardt, E., & Häring, H. U. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7331 · Cited by 22
Relative Hyperproinsulinemia as a Sign of Islet Dysfunction in Women with Impaired Glucose Tolerance
Larsson, H. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.6.2068 · Cited by 22
Breuer, T. G. K., Menge, B. A., Banasch, M., Uhl, W., Tannapfel, A., Schmidt, W. E., Nauck, M. A., & Meier, J. J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0330 · Cited by 20
Vauhkonen, I., Niskanen, L., Mykkänen, L., Haffner, S., Uusitupa, M., & Laakso, M. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430251 · Cited by 16 · cited 1×
“There have been some suggestions that proinsulin levels relative to the C-peptide levels would be more stronger markers to reflect the degree of hyperproinsulinemia than the normal P/I ratio [31,33,35], but we did not measure C-peptide levels in our study.”
BackgroundSelf-citationOzawa, S., Katsuta, H., Suzuki, K., Takahashi, K., Tanaka, T., Sumitani, Y., Nishida, S., Yoshimoto, K., & Ishida, H. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej13-0506 · Cited by 11 · cited 1×
“A β-cell defect could be either due to a primary dysfunction of the proinsulin conversion machinery (decreased activity of prohormone convertases 1/3) or a malfunction in related β-cell regulatory mechanisms that secondarily affect insulin production and secretion [4,5,8].”
BackgroundLorenzo, C., Hanley, A. J., Rewers, M., & Haffner, S. M. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0565-3 · Cited by 5 · cited 2×
“Conflicting results between the studies could be explained by small sample sizes in previous studies, different methods to measure proinsulin, cross-reactivity of proinsulin with proinsulin split products, and hepatic clearance of insulin [11,33,34].”
BackgroundResult
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Thomas, M. K., Nikooienejad, A., Bray, R., Cui, X., Wilson, J., Duffin, K., Milicevic, Z., Haupt, A., & Robins, D. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa863 · Cited by 345
“Elevated proinsulin levels predict both worsening of hyperglycemia and progression of nondiabetic subjects to T2D in longitudinal cohorts (16).”
BackgroundBiomarkers for type 2 diabetes
Laakso, M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.016 · Cited by 225
Self-citationThe Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases
Laakso, M., Kuusisto, J., Stančáková, A., Kuulasmaa, T., Pajukanta, P., Lusis, A. J., Collins, F. S., Mohlke, K. L., & Boehnke, M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.o072629 · Cited by 204
“Ketone bodies (13) Acetoacetate↑, -hydoxybutyrate↑ Acetoacetate↑ Non-cholesterol sterols (14) Desmosterol↑, campesterol↓, avenasterol↑ Desmosterol↑, campesterol↓, avenasterol↑ Glycerol, FAs (proton NMR) (15) Glycerol↑, free FAs↑, n-3 FAs↓, n-6 FAs↓, monounsaturated FAs↑, saturated n-7 and n-9 FAs↑ Glycerol↑, free FFA…”
BackgroundSelf-citationHyperinsulinemia: A cause of obesity?
Erion, K. A., & Corkey, B. E. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0261-z · Cited by 161
Metadata
- Authors
- Vangipurapu, J., Stančáková, A., Kuulasmaa, T., Kuusisto, J., & Laakso, M.
- Affiliations
- University of Eastern Finland (FI)
- Corresponding author
- Laakso, Markku
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-04-08
- Volume
- 10
- Issue
- 4
- Pages
- e0124028
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4390238
- OpenAlex
- W1965469192
- Cited by
- 46
- References
- 39
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 5
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Itä-Suomen Yliopisto
- Academy of Finland
- Kuopion Yliopistollinen Sairaala
- Diabetestutkimussäätiö
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- proinsulin, hyperproinsulinemia, hyperglycemia, type 2 diabetes, oral glucose tolerance test, beta-cell dysfunction, insulin sensitivity, insulin secretion, proinsulin/insulin ratio, Finnish men
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 2, Fasting, Finland, Follow-Up Studies, Glucose Tolerance Test, Humans, Hyperglycemia, Insulin, Insulin Resistance, Male, Middle Aged, Prognosis, Proinsulin, Biomarkers, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.